Interestingly, it has been pointed out that low-dose aspirin (75–100 mg), which mainly targets platelets, reduces the incidence and mortality of colorectal cancer (CRC) and other types of solid tumors (Rothwell et al., 2010, 2011, 2012; Patrignani and Patrono, 2016).